Dawn-bio ApS: Financial statements 2025
CVR: 43849662
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Dawn-bio ApS (CVR 43849662) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -638,228 and a net result of DKK -1,121,090 compared with DKK -1,568,059 the year before. Equity in the 2025 report amounted to DKK -3,434,479. The company had 1 employee in the financial year.
- Gross Profit
- DKK -638,228
- Profit/Loss
- DKK -1,121,090
- Equity
- DKK -3,434,479
- Total Assets
- DKK 1,015,622
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -638K | -1.1M | -3.4M | 1 |
| 2024 | - | -1.2M | -1.6M | -2.3M | 1 |
| 2023 | - | -562K | -785K | -745K | 1 |
Official annual report
How creditworthy is Dawn-bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Dawn-bio ApS has published its annual report for 2024. Gross profit came to DKK -1,208,662, and the net result was DKK -1,568,059.
As of May 23, 2025, Peter Greiner is registered as adm. dir. of Dawn-bio ApS.
About Dawn-bio ApS
Dawn-bio ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Greiner and Alok Javali. The company is owned by dawn-bio GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -638,228 and a net result of DKK -1,121,090 compared with DKK -1,568,059 the year before. Equity in the 2025 report amounted to DKK -3,434,479.